Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) FCF Margin (2016 - 2025)

Dare Bioscience's FCF Margin history spans 9 years, with the latest figure at 103.45% for Q4 2025.

  • For Q4 2025, FCF Margin rose 767001.0% year-over-year to 103.45%; the TTM value through Dec 2025 reached 997.01%, down 5182825.0%, while the annual FY2025 figure was 997.01%, 5182825.0% down from the prior year.
  • FCF Margin reached 103.45% in Q4 2025 per DARE's latest filing, up from 4418.13% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 56241.46% in Q2 2024 to a low of 73320.34% in Q1 2024.
  • Average FCF Margin over 4 years is 3617.27%, with a median of 799.59% recorded in 2023.
  • The largest YoY upside for FCF Margin was 5107103bps in 2025 against a maximum downside of -2991960bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 84.49% in 2022, then plummeted by -475bps to 486.0% in 2023, then tumbled by -1457bps to 7566.56% in 2024, then skyrocketed by 101bps to 103.45% in 2025.
  • Per Business Quant, the three most recent readings for DARE's FCF Margin are 103.45% (Q4 2025), 4418.13% (Q3 2025), and 26321.86% (Q2 2025).